Table 1

Participant characteristics

VariableOverweight control (n=28)Type 2 diabetes (T2DM) (n=26)p Value
Duration of T2DM, years (SD)NA5.1 (5.0)NA
Age, years (SD)59.8 (5.8)59.3 (5.7)0.39
Ethnicity, n (% Hispanic)1 (4)3 (12)0.34
Race, n (% Caucasian)27 (96)18 (67)0.01
Hypothesized physiological RPE predictors
 BMI, kg/m2 (SD)30.1 (2.8)31.3 (3.9)0.25
 HbA1c, %5.7 (0.3)6.8 (0.6)<0.001
 Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)4.0 (1.9)6.7 (4.6)0.01
 HTN prevalence (%)46500.99
 Pulse wave velocity (m/s)9.2 (0.7)9.9 (0.8)0.06
 Reported usual physical activity, MET h/week (SD)222 (35)231 (25)0.32
 VO2peak (mL/min)1470 (286)1313 (244)0.02
 VO2peak (mL/kg/min)17.8 (3.0)15.4 (2.5)0.003
 Work rate during 35% VO2peak (SD)43.5 (7.7)35.9 (7.1)<0.0001
 Heart rate during 8 min of exercise at 30 W (bpm)91 (2)102 (2)0.002
 Heart rate during 8 min of exercise at 35% VO2peak98 (3)105 (3)0.04
 Resting lactate concentrations (mmol/L)0.39 (0.03)0.65 (0.03)<0.0001
 Lactate during 8 min of exercise at 30 W (mmol/L)0.76 (0.10)1.18 (0.10)0.004
 Lactate at 8 min at 35% VO2peak (mmol/L)0.99 (0.10)1.28 (0.10)0.047
 τ2 at 30 W39.2 (13)36.2 (9.1)0.34
 τ2 at 35% VO2peak38.6 (12.2)38.5 (10.2)0.98
 Hypothesized behavioral RPE predictors
 Depressive symptoms
 CES-D11.4 (3.7)11.7 (5.6)0.77
 PHQ-93.3 (3.3)3.2 (3.2)0.96
 Self-efficacy scores
 Endurance self-efficacy746 (359)739 (264)0.94
 Lorig self-efficacy481 (95)479 (94)0.92
 Sallis self-efficacy45 (8)47 (8)0.23
  • Data expressed as mean (SE) for heart rate, lactate; data expressed as mean (SD) for all other continuous variables.

  • Missing data for <10% of participants with the exception of pulse wave velocity where we are missing 40% of data for each study group.

  • BMI, body mass index; CES-D, Center for Epidemiological Studies Depression; HbA1c, glycated hemoglobin; HTN, hypertension; PHQ-9, Patient Health Questionnaire-9; RER, respiratory exchange ratio; T2DM, type 2 diabetes mellitus.